Eli Lilly & Co. provided an upbeat sales forecast for the year Wednesday as strong demand for its weight loss drug cemented its position at the top of the obesity market.
www.bloomberg.com
#Lilly #Sees #Surging #Sales #Break #Weight #Loss #Rival #Novo
Lilly Sees Surging Sales in Break From Weight Loss Rival Novo
